UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000032406
Receipt No. R000036643
Scientific Title The effect of hormone therapy on chronic inflammation of endometriosis
Date of disclosure of the study information 2018/04/27
Last modified on 2021/05/02 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The effect of hormone therapy on chronic inflammation of endometriosis
Acronym The effect of Dienogest on chronic inflammation of endometriosis
Scientific Title The effect of hormone therapy on chronic inflammation of endometriosis
Scientific Title:Acronym The effect of Dienogest on chronic inflammation of endometriosis
Region
Japan

Condition
Condition endometriosis
Classification by specialty
Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess the effect of Dienogest on inflammatory cytokine and immune cells in endometriosis
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes To assess the number of immune cells especially regulatory T cells
Key secondary outcomes To assess the amount of inflammatory cytokines by ELISA or realtime PCR

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
50 years-old >=
Gender Female
Key inclusion criteria Inpatient for hysterectomy
can be informed consent
Key exclusion criteria intaking hormone therapy except Dienogest
pregnancy women
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Taisuke
Middle name
Last name Mori
Organization Kyoto Prefectural University of Medicine
Division name Obstetrics and Gynecology
Zip code 6028566
Address 465, Kajii-cho, Hirokoji, Kawaramachi-dori, Kyoto city, Kyoto, Japan
TEL 075-251-5560
Email moriman@koto.kpu-m.ac.jp

Public contact
Name of contact person
1st name Takuya
Middle name
Last name Sugahara
Organization Kyoto Prefectural University of Medicine
Division name Obstetrics and Gynecology
Zip code 6028566
Address 465, Kajii-cho, Hirokoji, Kawaramachi-dori, Kyoto city, Kyoto, Japan
TEL 075-251-5560
Homepage URL
Email sghr-tky@koto.kpu-m.ac.jp

Sponsor
Institute Kyoto Prefectural University of Medicine
Institute
Department

Funding Source
Organization Mochida pharmaceutical company
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kyoto Prefectural University of Medicine
Address 465, Kajii-cho, Hirokoji, Kawaramachi-dori, Kyoto city, Kyoto, Japan
Tel 075-251-5337
Email rinri@koto.kpu-m.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 27 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 04 Month 01 Day
Date of IRB
2017 Year 05 Month 31 Day
Anticipated trial start date
2018 Year 04 Month 27 Day
Last follow-up date
2021 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information None

Management information
Registered date
2018 Year 04 Month 27 Day
Last modified on
2021 Year 05 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000036643